EUVIMEDEUVIMED entdecken
Crossref

Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats

Sachin V Suryavanshi, Mayuresh S Garud, Kalyani Barve, Veeranjaneyulu Addepalli, Sachin V Utpat, Yogesh A Kulkarni

Pharmacology · 2020 · 105 (11-12) · 681-691

DOI: 10.1159/000508238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology, online erschienen am 16.07.2020. Verfasst von Sachin V Suryavanshi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, India. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Advanced glycation end products, oxidative stress, and TGF-β expression play a crucial role in pathophysiology of diabetic nephropathy. Inhibition of oxidative stress and TGF-β expression by natural traditional medicines may give an economic and safe alternative treatment option. Triphala churna, a traditional medicine, has been proved to have potent antioxidant activity, and individual components of it have shown significant antidiabetic activity. Hence, the present study was designed to study the effect of Triphala churna in diabetic nephropathy in rats.

Methods

Diabetes was induced in rats by administration of streptozotocin (55 mg/kg i.p.). Four weeks after induction of diabetes, the animals were treated with Triphala churna at the doses of 250, 500, and 1,000 mg/kg for next 4 weeks. Various biochemical and urine parameters such as glucose, creatinine, blood urea nitrogen (BUN), total protein, and albumin were assessed at the end of study. Creatinine clearance, BUN clearance, and glomerular filtration rate were determined. Oxidative stress parameters such as malondialdehyde, catalase, reduced glutathione, and superoxide dismutase were determined in kidney tissues. TGF-β1 expression was measured with ELISA, immunohistochemistry, and western blot techniques. Histopathology study was carried out with haemotoxylin and eosin, periodic acid-Schiff, and Masson’s trichrome staining to determine histological changes.

Results

Treatment with Triphala churna significantly improved urine parameters. Triphala churna treatment also improved plasma proteins, albumin, creatinine, and BUN levels. The oxidative stress was reduced in the kidney with the treatment of Triphala churna. Histopathological studies revealed that Triphala churna reduced kidney damage. Immunohistochemistry, ELISA, and western blotting study revealed that treatment with Triphala decreased the expression of TGF-β in kidney tissues.

Conclusion

From the results, it can be concluded that Triphala churna has a significant nephroprotective effect because of its capability of inhibiting oxidative stress and TGF-β in diabetes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbuminsAnimalsAntioxidantsBlood GlucoseBlood ProteinsBlood Urea NitrogenCreatinineDiabetes Mellitus, ExperimentalDiabetic NephropathiesDose-Response Relationship, DrugKidneyMaleOxidative StressPlant ExtractsRatsRats, Sprague-DawleyStreptozocinTransforming Growth Factor beta1

Stichwörter der Autor:innen

Diabetic complicationsDiabetic nephropathyEmblica officinalisTerminalia belericaTerminalia chebulaTriphala churna

Substanzen

AlbuminsAntioxidantsBlood GlucoseBlood ProteinsPlant ExtractsTransforming Growth Factor beta1triphalaStreptozocinCreatinine

Autor:innen und Institutionen

  • Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, India.
  • MES Ayurveda Mahavidyalaya, Ghanekhunt-Lote, Tal-Khed, Ratnagiri, India.
  • Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, Mumbai, India, yogeshkulkarni101@yahoo.com.

Zitieren

APA

Suryavanshi, S. V., Garud, M. S., Barve, K., Addepalli, V., Utpat, S. V., & Kulkarni, Y. A. (2020). Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats. Pharmacology, 105(11-12), 681-691. https://doi.org/10.1159/000508238

Vancouver

Suryavanshi SV, Garud MS, Barve K, Addepalli V, Utpat SV, Kulkarni YA. Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats. Pharmacology. 2020;105(11-12):681-691. doi:10.1159/000508238

BibTeX
@article{Suryavanshi2020,
  author = {Suryavanshi, Sachin V and Garud, Mayuresh S and Barve, Kalyani and Addepalli, Veeranjaneyulu and Utpat, Sachin V and Kulkarni, Yogesh A},
  title = {Triphala Ameliorates Nephropathy via Inhibition of TGF-β1 and Oxidative Stress in Diabetic Rats},
  journal = {Pharmacology},
  year = {2020},
  volume = {105},
  number = {11-12},
  pages = {681--691},
  doi = {10.1159/000508238}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche